News

The new tool will also be localized to provide relevant medical information. 

CEO Adrian Gilmore said the company is looking at strategic partnerships, M&A and other general scaling of the business in the year to come.

Deloitte is also working with Amgen to create a tool specifically designed to support patients in new therapies. 

The VentureConnect series will include a Startup Showcase at the JP Morgan Healthcare Conference in San Francisco and a Startup Pitch Competition at the HIMSS20 Global Conference in Orlando.

The company plans to use the funding to expand its capabilities to identify more conditions incuding schizophrenia and multiple sclerosis. 

Digital and remote clinical trial designs have plenty to offer in terms of cost and efficiency, but data handling and other concerns suggest there's still work to be done, according to experts at the American Heart Association Scientific Sessions 2019 in Philadelphia.

The acquisition will include Biovotions' wearables, patents, staff, partners and clients.